Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin light chain pseudogene 12 (FTLP12) is a human pseudogene located on chromosome 17[4][6]. Pseudogenes are segments of DNA that resemble genes but are generally non-functional due to mutations or lack of regulatory elements; they do not produce functional proteins[6][2]. FTLP12 is a non-coding remnant related to the functional ferritin light chain gene (FTL), which plays a key role in iron storage and metabolism. FTLP12 itself is not considered a therapeutic target and does not have a known biological or pathological role in human health or disease[6][2].\n\nFTLP12 should not be confused with the functional ferritin light chain gene (FTL), which is involved in iron storage, oxidative stress protection, and certain neurodegenerative diseases[1][5]. FTLP12’s primary significance lies in genomic annotation and evolutionary studies, rather than any direct functional or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin light chain pseudogene 12 (FTLP12).